Who Should Use the New Diagnostic Guidelines? The Debate Continues
conference story), and in a Webinar with some of the developers of an international and a U.S. set of
Upcoming Webinars
No Upcoming Webinars AvailableALL WEBINARS
68 RESULTS
You searched webinars/26.
Sort By:
- Most Recent
- Most Commented
- Most Relevant
New Frontier: Developing Outcome Measures for Pre-dementia Trials
Administration shared his viewpoint and answered questions about the new guidance. Listen to the Webinar
Non-coding RNAs in Neurodegeneration
Peter T. Nelson led this Webinar from 12:00-1:30 p.m. (U.S. Eastern Time) on Friday, 26 October
Slow Aβ; Clearance Is ApoE4’s Modus Operandi in Late-Onset AD
a Webinar discussion of a new Alzheimer’s disease research study published 29 June 2011. The journal
Mice on Trial? Issues in the Design of Drug Studies
of Prize4Life for helping to organize this discussion. View/Listen to the Webinar Transcript:
Intraneuronal Aβ: Was It APP All Along?
On 16 June 2011, ARF held a Webinar with Eddie Lee, Todd Golde, Gunnar Gouras, Frank LaFerla,
Targeting Tumor Necrosis Factor—A Therapeutic Strategy for AD
Webinar/live discussion was held Thursday, June 12, from noon to 1:30 p.m. (EST). {C} Transcript: Participants:
Susceptibility Testing and Risk Assessment in Alzheimer Disease
prepared two introductory texts for this discussion. Robert Green led this Webinar on 15 June 2007. Readers
Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.
Current Filters
- Keyword: webinars/26. x